41 related articles for article (PubMed ID: 118112)
1. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
Håkansson L; Hällgren R; Venge P
Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
[TBL] [Abstract][Full Text] [Related]
2. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
Schifferli JA; Woo P; Peters DK
Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
[TBL] [Abstract][Full Text] [Related]
3. Enzyme immunoassay of complement-binding rheumatoid factors.
Teppo AM; Maury CP
Rheumatol Int; 1986; 6(1):31-5. PubMed ID: 3538345
[TBL] [Abstract][Full Text] [Related]
4. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
Wager O
Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
[No Abstract] [Full Text] [Related]
5. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
6. Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo.
Hällgren R
Immunology; 1979 Nov; 38(3):529-37. PubMed ID: 118112
[TBL] [Abstract][Full Text] [Related]
7. Kinetic measurement of the interaction of rheumatoid factor with IgG-coated latex particles and the influence of the first component of human complement.
Hällgren R
Clin Exp Immunol; 1980 Jan; 39(1):154-63. PubMed ID: 6771071
[TBL] [Abstract][Full Text] [Related]
8. Kinetic studies of the association of complement components and IgG-coated latex particles incubated in normal or complement-activated human serum.
Hällgren R
Clin Exp Immunol; 1981 Apr; 44(1):191-200. PubMed ID: 7261475
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the agglutination of IgG-coated latex particles by C1q: the influence of heat-labile serum components.
Hällgren R; Stålenheim G; Venge P
Scand J Immunol; 1979; 9(4):365-72. PubMed ID: 441683
[TBL] [Abstract][Full Text] [Related]
10. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
Doekes G; Schouten J; Cats A; Daha MR
Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
[TBL] [Abstract][Full Text] [Related]
12. THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.
NAFF GB; PENSKY J; LEPOW IH
J Exp Med; 1964 Apr; 119(4):593-613. PubMed ID: 14151101
[TBL] [Abstract][Full Text] [Related]
13. CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.
BORSOS T; RAPP HJ
J Immunol; 1963 Dec; 91():851-8. PubMed ID: 14106311
[No Abstract] [Full Text] [Related]
14. Titration of the first component of complement on a molecular basis: suitability of IgM and unsuitability of IgG hemolysins as sensitizer.
Colten HR; Borsos T; Rapp HJ
Immunochemistry; 1969 May; 6(3):461-7. PubMed ID: 5786936
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
